Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02561832
Title A Study to Assess the Safety, Tolerability and Efficacy of Olaparib in Combination With Carboplatin in Patients With HER-2 Negative Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Research Site New York New York 10065 United States Details
Research Site Stony Brook New York 11794 United States Details
Research Site Barcelona 08035 Spain Details
Research Site Madrid 28034 Spain Details
Research Site Madrid 28050 Spain Details
Research Site Valencia 46010 Spain Details
Research Site Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field